CBD oil fails to reduce pain after common treatment for urinary stones – Medical Marijuana Program Connection

Researchers have found in First randomized trial of CBD for pain control after urinary stone treatment that treatment with cannabidiol (CBD) oil product fails to lower pain scores after surgical treatment and stent placement for patients with urinary stones.

The findings of the clinical trial have been published in the April issue of The Journal of Urology, an Official Journal of the American Urological Association (AUA).

“Urologists and patients alike are interested in finding effective alternatives to pain management after urinary stone treatment,” comments senior author Karen Stern, MD, of Mayo Clinic Phoenix, Ariz. “Our study found that although treatment with CBD oil was safe, it wasn’t effective in minimizing pain or opioid use after ureteroscopy [URS] and stent placement.”

Urinary stones located in the kidney or ureter are one of the most common problems treated by urologists. Stones that are too large to pass on their own may be treated surgically, using an instrument called a ureteroscope to remove or fragment the stones. In most cases, a soft plastic tube called a stent is placed to ensure that urine can drain from the kidney into the bladder until swelling of the ureter resolves.

Many patients find the stent uncomfortable and painful, leading to the need for pain medications – often including opioids. Opioid use after URS is a risk factor for opioid dependence, therefore there has been a significant movement towards finding alternatives for relieving…